These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29702145)

  • 1. Activation of M2 muscarinic acetylcholine receptors by a hybrid agonist enhances cytotoxic effects in GB7 glioblastoma cancer stem cells.
    Cristofaro I; Spinello Z; Matera C; Fiore M; Conti L; De Amici M; Dallanoce C; Tata AM
    Neurochem Int; 2018 Sep; 118():52-60. PubMed ID: 29702145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.
    Guerriero C; Matera C; Del Bufalo D; De Amici M; Conti L; Dallanoce C; Tata AM
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of M2 muscarinic receptor inhibits cell growth and survival in human glioblastoma cancer stem cells.
    Alessandrini F; Cristofaro I; Di Bari M; Zasso J; Conti L; Tata AM
    Int Immunopharmacol; 2015 Nov; 29(1):105-9. PubMed ID: 26033491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells.
    Di Bari M; Tombolillo V; Conte C; Castigli E; Sciaccaluga M; Iorio E; Carpinelli G; Ricordy R; Fiore M; Degrassi F; Tata AM
    Neurochem Int; 2015 Nov; 90():261-70. PubMed ID: 26455407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells.
    Ferretti M; Fabbiano C; Di Bari M; Conte C; Castigli E; Sciaccaluga M; Ponti D; Ruggieri P; Raco A; Ricordy R; Calogero A; Tata AM
    J Cell Mol Med; 2013 Apr; 17(4):552-66. PubMed ID: 23490231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross Interaction between M2 Muscarinic Receptor and Notch1/EGFR Pathway in Human Glioblastoma Cancer Stem Cells: Effects on Cell Cycle Progression and Survival.
    Cristofaro I; Alessandrini F; Spinello Z; Guerriero C; Fiore M; Caffarelli E; Laneve P; Dini L; Conti L; Tata AM
    Cells; 2020 Mar; 9(3):. PubMed ID: 32182759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M2 Muscarinic Receptor Stimulation Induces Autophagy in Human Glioblastoma Cancer Stem Cells via mTOR Complex-1 Inhibition.
    Guerriero C; Manfredelli M; Matera C; Iuzzolino A; Conti L; Dallanoce C; De Amici M; Trisciuoglio D; Tata AM
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M2 muscarinic receptors inhibit cell proliferation in human glioblastoma cell lines.
    Ferretti M; Fabbiano C; Di Bari M; Ponti D; Calogero A; Tata AM
    Life Sci; 2012 Nov; 91(21-22):1134-7. PubMed ID: 22575825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M2 Muscarinic Receptor Activation Impairs Mitotic Progression and Bipolar Mitotic Spindle Formation in Human Glioblastoma Cell Lines.
    Di Bari M; Tombolillo V; Alessandrini F; Guerriero C; Fiore M; Asteriti IA; Castigli E; Sciaccaluga M; Guarguaglini G; Degrassi F; Tata AM
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M2 Receptor Activation Counteracts the Glioblastoma Cancer Stem Cell Response to Hypoxia Condition.
    Cristofaro I; Limongi C; Piscopo P; Crestini A; Guerriero C; Fiore M; Conti L; Confaloni A; Tata AM
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mir-34a-5p Mediates Cross-Talk between M2 Muscarinic Receptors and Notch-1/EGFR Pathways in U87MG Glioblastoma Cells: Implication in Cell Proliferation.
    Di Bari M; Bevilacqua V; De Jaco A; Laneve P; Piovesana R; Trobiani L; Talora C; Caffarelli E; Tata AM
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells.
    Pacini L; De Falco E; Di Bari M; Coccia A; Siciliano C; Ponti D; Pastore AL; Petrozza V; Carbone A; Tata AM; Calogero A
    Cancer Biol Ther; 2014; 15(11):1489-98. PubMed ID: 25482946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells.
    Lucianò AM; Perciballi E; Fiore M; Del Bufalo D; Tata AM
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
    Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
    May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
    Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Muscarinic Acetylcholine Receptor-2 in the Cerebellar Cortex in Cardiovascular Modulation in Anaesthetized Rats.
    Zhang C; Sun T; Zhou P; Zhu Q; Zhang L
    Neurochem Res; 2016 Apr; 41(4):804-12. PubMed ID: 26526144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.
    Schrage R; Seemann WK; Klöckner J; Dallanoce C; Racké K; Kostenis E; De Amici M; Holzgrabe U; Mohr K
    Br J Pharmacol; 2013 May; 169(2):357-70. PubMed ID: 23062057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.
    Del Bello F; Bonifazi A; Quaglia W; Mazzolari A; Barocelli E; Bertoni S; Matucci R; Nesi M; Piergentili A; Vistoli G
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3255-9. PubMed ID: 24980056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2 muscarinic receptor activation inhibits cell proliferation and migration of rat adipose-mesenchymal stem cells.
    Piovesana R; Melfi S; Fiore M; Magnaghi V; Tata AM
    J Cell Physiol; 2018 Jul; 233(7):5348-5360. PubMed ID: 29227527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.